To see the effectiveness of ETT with Subglottic suction device in prevention of VAP over conventional ET tube

Active, not recruiting

• Conditions: Diseases of the respiratory system,

• Registration Number: CTRI/2023/03/050983
• Lead Sponsor: Post graduate institute of medical education and research chandigarh

Brief Summary

This is an open label parallel group randomised control trial to study the effect of subglottic suction device(SSD) with intermittent subglottic suction in prevention of VAP. This study focus on incidence of VAP in the group receiving SSD vs patient with standard ET care.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-03-28
• Last Update Posted: 2024-04-01

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Neurological symptoms CVS symptoms sepsis and MODS Poisoning patients Snake venum patients.

Exclusion Criteria

• community acquired pneumonia 2.
• Hospital acquired pneumonia 3.
• Immunocompromised hosts 5.
• Trauma patients 6.
• Pregnant females 7.
• Surgical patients 8.
• COVID positive patients 9.
• Intubated outside PGIMER.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of VAP	14days

Secondary Outcome Measures

Name	Time	Method
Secondary VAP	Length of stay

Trial Locations

Locations (1)

PGIMER ( Nehru hospital); 🇮🇳 Chandigarh, CHANDIGARH, India

PGIMER ( Nehru hospital)

🇮🇳Chandigarh, CHANDIGARH, India

Dr Pallvi

Principal investigator

8278772101

Pallvibhardwaj56@gmail.com